prospectivaconsultoria.com.br

The German pharmaceutical Boehringer Ingelheim plans to launch over the next three years oncology drugs from its pipeline in Brazil, and should focus on this segment. The company already makes clinical trial in the country.

See more: Valor Econômico

Rafael Dubeaux analyses economic and technological developments in Brazil vis-a-vis Republic of Korea in perspective of international regimes.

Read more: Publisher Juruá

In Telebrás´s acquisitions, the origin of the product will be more important than price for the supplier choice, according to the prerogatives of Provisional Measure nº 495 which favors domestic industry in government procurement.

Read more: Valor Econômico

Sao Paulo State Science Park System has started to build the infrastructure which will host sectors of information technology, pharmaceuticals, biotechnology and nanotechnology. It will be the largest science park in Latin America.